Multi-Omics Integration in Rare Disease Clinical Studies
Multi-Omics Integration in Rare Disease Clinical Studies Harnessing Multi-Omics Integration to Advance Rare Disease Clinical Research The Promise of Multi-Omics in Rare Disease Research Rare disease clinical studies often face significant barriers such as small patient populations, limited biomarkers, and heterogeneous disease manifestations. Multi-omics integration—combining genomics, transcriptomics, proteomics, metabolomics, and epigenomics—offers a holistic approach to…
Read More “Multi-Omics Integration in Rare Disease Clinical Studies” »